Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 498 of 1,261

  1. US 10294215

    Therapeutically active compounds and their methods of use

    Agios Pharmaceuticals, Inc. · Granted May 21, 2019 · Expires May 16, 2039

    granted

  2. US 10293049

    Etanercept formulations stabilized with amino acids

    Coherus BioSciences, Inc. · Granted May 21, 2019 · Expires May 16, 2039

    granted

  3. US 2019144465

    Macrocyclic MCL-1 inhibitors and methods of use

    ABBVIE INC [US] · Granted May 16, 2019 · Expires May 11, 2039

    granted

  4. US 10287340

    Anti-HIV domain antibodies and method of making and using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 14, 2019 · Expires May 9, 2039

    granted

  5. US 10287606

    Genomic engineering of pluripotent cells

    Fate Therapeutics, Inc. · Granted May 14, 2019 · Expires May 9, 2039

    granted

  6. US 10285980

    Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease

    PTC THERAPEUTICS, INC. · Granted May 14, 2019 · Expires May 9, 2039

    granted

  7. US 10285988

    Compounds for treatment of fibrosis diseases

    Curegenix, Inc. · Granted May 14, 2019 · Expires May 9, 2039

    granted

  8. US 10287284

    Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof

    VTV THERAPEUTICS LLC · Granted May 14, 2019 · Expires May 9, 2039

    granted

  9. US 10286079

    Modified cytotoxins and their therapeutic use

    The Regents of the University of California · Granted May 14, 2019 · Expires May 9, 2039

    granted

  10. US 10286011

    Compositions and methods for transplantation of colon microbiota

    Regents of the University of Minnesota · Granted May 14, 2019 · Expires May 9, 2039

    granted

  11. US 10287295

    TGF-β inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 14, 2019 · Expires May 9, 2039

    granted

  12. US 10286064

    Cationic lipid vaccine compositions and methods of use

    THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SEC. OF THE DEPT. OF HEALTH AND HUMAN SERVICES · Granted May 14, 2019 · Expires May 9, 2039

    granted

  13. US 10286050

    Multi-epitope TARP peptide vaccine and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 14, 2019 · Expires May 9, 2039

    granted

  14. US 10285940

    Multicomponent, internally structured nanoemulsions and methods of production

    The Regents of the University of California · Granted May 14, 2019 · Expires May 9, 2039

    granted

  15. US 10287350

    Chimeric antigen receptors targeting CD-19

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 14, 2019 · Expires May 9, 2039

    granted

  16. US 10287334

    Non-narcotic CRMP2 peptides targeting sodium channels for chronic pain

    Arizona Board of Regents on Behalf of the University of Arizona · Granted May 14, 2019 · Expires May 9, 2039

    granted

  17. US 10291197

    Compositions of influenza hemagglutinin with heterologous epitopes and/or altered maturation cleavage sites and methods of use thereof

    CG Discovery, Inc. · Granted May 14, 2019 · Expires May 9, 2039

    granted

  18. US 10287584

    Compounds and methods for the modulation of COMP

    The Board of Regents of the University of Texas System · Granted May 14, 2019 · Expires May 9, 2039

    granted

  19. US 10287572

    Protein scaffolds and methods of use

    Regents of the University of Minnesota · Granted May 14, 2019 · Expires May 9, 2039

    granted

  20. US 10287582

    Organic compositions to treat HSF1-related diseases

    Arrowhead Pharmaceuticals, Inc. · Granted May 14, 2019 · Expires May 9, 2039

    granted

  21. US 10287596

    Regulating alkaloids

    22ND CENTURY LIMITED, LLC · Granted May 14, 2019 · Expires May 9, 2039

    granted

  22. US 10287355

    Methods and compositions for modulating lymphangiogenesis, E.G., to treat transplant rejection, in a subject

    The Regents of the University of California · Granted May 14, 2019 · Expires May 9, 2039

    granted

  23. US 10287564

    Procoagulant compounds

    BIOVERATIV THERAPEUTICS INC. · Granted May 14, 2019 · Expires May 9, 2039

    granted

  24. US 10287297

    Epoxyazulene derivatives useful for treating cancer and diabetes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 14, 2019 · Expires May 9, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.